News & Events

Event

Mar 27 - Mar 29, 2017

Oligonucleotide and Peptide Therapeutics (OPT)

Oligonucleotide and Peptide Therapeutics (OPT) Boston has been established to convene leading developers and technology providers to discuss advances in the discovery, development and delivery of next-generation oligonucleotide and peptide therapies. This three-day event includes two main conferences covering topics within discovery, clinical development, delivery, formulation and manufacturing, as well as two symposia focused on applications within oncology and immunotherapy.

Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes. Pick up your copy of this essential resource at OPT Boston!